This review focuses on the literature published during the 13 months from December 2016 to December 2017 that is of interest to anesthesiologists taking care of children and adults with congenital heart disease. Five themes are addressed during this time period and 100 peer-reviewed articles are discussed.
IngRJTwiteMD. The year in review: anesthesia for congenital heart disease 2013. Semin Cardiothorac Vasc Anesth. 2014;18:17-23.
2.
IngRJTwiteMD. The year in review: anesthesia for congenital heart disease 2014. Semin Cardiothorac Vasc Anesth. 2015;19:12-20.
3.
TwiteMIngRJ. Noteworthy literature in 2015: anesthesia for congenital heart disease. Semin Cardiothorac Vasc Anesth. 2016;20:14-23.
4.
IngRJTwiteM. Noteworthy literature published in 2016. Semin Cardiothorac Vasc Anesth. 2017;21:17-22.
5.
US Food and Drug Administration. FDA drug safety communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm. Accessed December 29, 2017.
6.
DavidsonAJDismaNde GraaffJCet al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016;387:239-250.
7.
US Food and Drug Administration. FDA drug safety communication: FDA approves label changes for use of general anesthetic and sedation drugs in young children. https://www.fda.gov/Drugs/DrugSafety/ucm554634.htm. Accessed December 26, 2017.
8.
VutskitsLXieZ. Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci. 2016;17:705-717.
9.
AndropoulosDBGreeneMF. Anesthesia and developing brains—implications of the FDA warning. N Engl J Med. 2017;376:905-907.
10.
AdlerACChenKAndropoulosDB. Safety of anesthetics in children. J Am Coll Surg. 2017;224:1000-1001.
11.
PolanerDMZukJMcCannMEDavidsonA. Warnings, uncertainty, and clinical practice. Lancet. 2017;389:2174-2176.
12.
DavidsonAVutskitsL. The new FDA drug safety communication on the use of general anesthetics in young children: what should we make of it?Paediatr Anaesth. 2017;27:336-337.
13.
PinyavatTWarnerDOFlickRPet al. Summary of the update session on clinical neurotoxicity studies. J Neurosurg Anesthesiol. 2016;28:356-360.
14.
GlatzPSandinRHPedersenNLBonamyAKErikssonLIGranathF. Association of anesthesia and surgery during childhood with long-term academic performance. JAMA Pediatr. 2017;171:e163470.
15.
O’LearyJDJanusMDukuEet al. A population-based study evaluating the association between surgery in early life and child development at primary school entry. Anesthesiology. 2016;125:272-279.
16.
GrahamMRBrownellMChateauDGDraganRDBurchillCFransooRR. Neurodevelopmental assessment in kindergarten in children exposed to general anesthesia before the age of 4 years: a retrospective matched cohort study. Anesthesiology. 2016;125:667-677.
17.
IngCHegartyMKPerkinsJWet al. Duration of general anaesthetic exposure in early childhood and long-term language and cognitive ability. Br J Anaesth. 2017;119:532-540.
18.
RotermannILogotetaJFaltaJet al. Neuro-developmental outcome in single-ventricle patients: is the Norwood procedure a risk factor?Eur J Cardiothorac Surg. 2017;52:558-564.
19.
PeyvandiSKimHLauJet al. The association between cardiac physiology, acquired brain injury, and postnatal brain growth in critical congenital heart disease. J Thorac Cardiovasc Surg. 2018;155:291-300.e3. doi:10.1016/j.jtcvs.2017.08.019.
20.
RollinsCKAsaroLAAkhondi-AslAet al. White matter volume predicts language development in congenital heart disease. J Pediatr. 2017;181:42-48.e2.
VedovelliLPadalinoMD’AroncoSet al. Corrigendum to: Glial fibrillary acidic protein plasma levels are correlated with degree of hypothermia during cardiopulmonary bypass in congenital heart disease surgery [Interact CardioVasc Thorac Surg 2017]. Interact Cardiovasc Thorac Surg. 2017;25:164.
23.
TrakasEDomninaYPanigrahyAet al. Serum neuronal biomarkers in neonates with congenital heart disease undergoing cardiac surgery. Pediatr Neurol. 2017;72:56-61.
24.
AlySAZurakowskiDGlassPSkurow-ToddKJonasRADonofrioMT. Cerebral tissue oxygenation index and lactate at 24 hours postoperative predict survival and neurodevelopmental outcome after neonatal cardiac surgery. Congenit Heart Dis. 2017;12:188-195.
25.
CharDRamamoorthyCWise-FaberowskiL. Cognitive dysfunction in children with heart disease: the role of anesthesia and sedation. Congenit Heart Dis. 2016;11:221-229.
26.
MooreJWVincentRNBeekmanRH3rdet al. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2014;64:2439-2451.
27.
JayaramNSpertusJAKennedyKFet al. Modeling major adverse outcomes of pediatric and adult patients with congenital heart disease undergoing cardiac catheterization: observations from the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment). Circulation. 2017;136:2009-2019.
28.
KennyDPHijaziZM. Current status and future potential of transcatheter interventions in congenital heart disease. Circ Res. 2017;120:1015-1026.
RajiahPTandonAGreilGFAbbaraS. Update on the role of cardiac magnetic resonance imaging in congenital heart disease. Curr Treat Options Cardiovasc Med. 2017;19:2.
31.
RajiahPSabooSSAbbaraS. Role of CT in congenital heart disease. Curr Treat Options Cardiovasc Med. 2017;19:6.
32.
MasaracchiaMMTsapakosMJMcNultyNJBeachML. Changing the paradigm for diagnostic MRI in pediatrics: don’t hold your breath. Paediatr Anaesth. 2017;27:880-884.
33.
ValverdeIGomez-CirizaGHussainTet al. Three-dimensional printed models for surgical planning of complex congenital heart defects: an international multicentre study. Eur J Cardiothorac Surg. 2017;52:1139-1148.
VenerDFPasqualiSKMossadEB. Anesthesia and databases: pediatric cardiac disease as a role model. Anesth Analg. 2017;124:572-581.
36.
JacobsJPMayerJEJrMavroudisCet al. The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2017 update on outcomes and quality. Ann Thorac Surg. 2017;103:699-709.
37.
IngRJTwiteMBarrettC. Review of the Society of Thoracic Surgeons Congenital Heart Surgery Database: 2017 update on outcomes and quality implications for the anesthesiologist. J Cardiothorac Vasc Anesth. 2017;31:1934-1938.
38.
JaffrayJMahajerinAYoungGet al. A multi-institutional registry of pediatric hospital-acquired thrombosis cases: the Children’s Hospital-Acquired Thrombosis (CHAT) project. Thromb Res. 2017;161:67-72.
39.
GuzzettaNA. Thrombosis in neonates and infants after cardiac surgery—another piece of the puzzle. J Cardiothorac Vasc Anesth. 2017;31:1949-1951.
40.
FaraoniDEmaniSHalpinEet al. Relationship between transfusion of blood products and the incidence of thrombotic complications in neonates and infants undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31:1943-1948.
41.
HuntRHoffmanCMEmaniSet al. Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease. J Thromb Haemost. 2017;15:2306-2316.
42.
GautamNKCaiCPawelekORafiqueMBCattanoDPivalizzaEG. Performance of functional fibrinogen thromboelastography in children undergoing congenital heart surgery. Paediatr Anaesth. 2017;27:181-189.
43.
RizzaARicciZPezzellaCet al. Kaolin-activated thromboelastography and standard coagulation assays in cyanotic and acyanotic infants undergoing complex cardiac surgery: a prospective cohort study. Paediatr Anaesth. 2017;27:170-180.
44.
RajkumarVKumarBDuttaVMishraAKPuriGD. Utility of sonoclot in prediction of postoperative bleeding in pediatric patients undergoing cardiac surgery for congenital cyanotic heart disease: a prospective observational study. J Cardiothorac Vasc Anesth. 2017;31:901-908.
45.
MatterRMRagabIARoushdyAMAhmedAGAlyHHIsmailEA. Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: role of immature platelet fraction [published online September 7, 2017]. Congenit Heart Dis. doi:10.1111/chd.12530.
46.
SilveyMBrandãoLR. Risk factors, prophylaxis, and treatment of venous thromboembolism in congenital heart disease patients. Front Pediatr. 2017;5:146.
47.
WanDTsuiCKiessMGrewalJKrahnADChakrabartiS. Anticoagulation for thromboembolic risk reduction in adults with congenital heart disease. Can J Cardiol. 2017;33:1597-1603.
48.
KarimiMSullivanJMLererTHronekC. National trends and variability in blood utilization in paediatric cardiac surgery. Interact Cardiovasc Thorac Surg. 2017;24:938-943.
49.
BianchiPCotzaMBeccarisCet al; Surgical and Clinical Outcome REsearch (SCORE) group. Early or late fresh frozen plasma administration in newborns and small infants undergoing cardiac surgery: the APPEAR randomized trial. Br J Anaesth. 2017;118:788-796.
50.
SchmidtBSJordanJELaneMRet al. Timing of adding blood to prime affects inflammatory response to neonatal cardiopulmonary bypass. Cardiol Young. 2017;27:480-487.
51.
GuzzettaNAWilliamsGD. Current use of factor concentrates in pediatric cardiac anesthesia. Paediatr Anaesth. 2017;27:678-687.
52.
EdwinFZühlkeLFaroukHet al. Status and challenges of care in Africa for adults with congenital heart defects. World J Pediatr Congenit Heart Surg. 2017;8:495-501.
53.
BaehnerTEllerkmannRK. Anesthesia in adults with congenital heart disease. Curr Opin Anaesthesiol. 2017;30:418-425.
54.
LuiGKSaidiABhattABet al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017;136:e348-e392.
55.
Alonso-GonzalezR. Liver dysfunction and congenital heart disease: are we ready for the epidemic?Int J Cardiol. 2017;249:169-170.
56.
AdachiKToyamaHKaihoYAdachiOHudetaHYamauchiM. The impact of liver disorders on perioperative management of reoperative cardiac surgery: a retrospective study in adult congenital heart disease patients. J Anesth. 2017;31:170-177.
57.
MebusSNagdymanNKügelJet al. Non-invasive assessment of liver changes in Eisenmenger patients. Int J Cardiol. 2017;249:140-144.
58.
Buendia-FuentesFMelero-FerrerJLPlaza-LopezDet al. Noninvasive liver assessment in adult patients with Fontan circulation using acoustic radiation force impulse elastography and hepatic magnetic resonance imaging. World J Pediatr Congenit Heart Surg. 2018;9:22-30.
59.
WuFMKogonBEaringMGet al. Liver health in adults with Fontan circulation: a multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017;153:656-664.
60.
EvansWNAchermanRJCiccoloMLet al. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: preliminary findings [published online December 1, 2017]. Congenit Heart Dis. doi:10.1111/chd.12558.
61.
VeldtmanGROpotowskyARWittekindSGet al. Cardiovascular adaptation to the Fontan circulation. Congenit Heart Dis. 2017;12:699-710.
62.
HaysBSBakerMLaibAet al. Histopathological abnormalities in the central arteries and veins of Fontan subjects [published online September 29, 2017]. Heart. doi:10.1136/heartjnl-2017-311838.
63.
EgbeACKhanARAmmashNMet al. Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures. Heart. 2017;103:1813-1820.
64.
MarroneCFerreroPUricchioNet al. The unnatural history of failing univentricular hearts: outcomes up to 25 years after heart transplantation. Interact Cardiovasc Thorac Surg. 2017;25:892-897.
65.
MatsudaHIchikawaHUenoTSawaY. Heart transplantation for adults with congenital heart disease: current status and future prospects. Gen Thorac Cardiovasc Surg. 2017;65:309-320.
66.
MenachemJNGolbusJRMolinaMet al. Successful cardiac transplantation outcomes in patients with adult congenital heart disease. Heart. 2017;103:1449-1454.
67.
PasupnetiSDhillonGReitzBKhushK. Combined heart lung transplantation: an updated review of the current literature. Transplantation. 2017;101:2297-2302.
68.
TullohRDimopoulosKCondliffeRCliftP; CHAMPION Steering Committee. Management of adults with congenital heart disease and pulmonary arterial hypertension in the UK: survey of current practice, unmet needs and expert commentary [published online November 13, 2017]. Heart Lung Circ. doi:10.1016/j.hlc.2017.10.018.
69.
SchuijtMTUBlokIMZwindermanAHet al. Mortality in pulmonary arterial hypertension due to congenital heart disease: serial changes improve prognostication. Int J Cardiol. 2017;243:449-453.
70.
PriceLCDimopoulosKMarinoPet al. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension. Thorax. 2017;72:1035-1045.
71.
CanobbioMMWarnesCAAboulhosnJet al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135:e50-e87.
72.
LadouceurMBenoitLRadojevicJet al. Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. Heart. 2017;103:287-292.
73.
CauldwellMSteerPJBonnerSet al. Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair [published online September 27, 2017]. Heart. doi:10.1136/heartjnl-2017-311763.
74.
BonnetVSimonetTLabombardaFet al. Neonatal and maternal outcomes of pregnancy with maternal cardiac disease (the NORMANDY study): years 2000-2014 [published online January 30, 2017]. Anaesth Crit Care Pain Med. doi:10.1016/j.accpm.2017.01.005.
75.
LadouceurMBenoitLBasquinAet al. How pregnancy impacts adult cyanotic congenital heart disease: a multicenter observational study. Circulation. 2017;135:2444-2447.
76.
van HagenIMRoos-HesselinkJWDonvitoVet al. Incidence and predictors of obstetric and fetal complications in women with structural heart disease. Heart. 2017;103:1610-1618.
77.
Roos-HesselinkJWBudtsWWalkerFet al. Organisation of care for pregnancy in patients with congenital heart disease. Heart. 2017;103:1854-1859.
78.
KozickaUWerońskiKRużylloWet al. Pregnancy after transcatheter pulmonary valve implantation. Can J Cardiol. 2017;33:1737.e5-1737.e7.
79.
MontanaroCDimopoulosKShoreDF. Infective endocarditis in patients with congenital heart disease: when, where and how. Int J Cardiol. 2017;249:171-172.
80.
MooreBCaoJKotchetkovaICelermajerDS. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol. 2017;249:161-165.
81.
TutarelOAlonso-GonzalezRMontanaroCet al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart. 2018;104:161-165.
82.
MylotteDRushaniDTherrienJet al. Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves. Am J Cardiol. 2017;120:2278-2283.
83.
LluriGLeviDSMillerEet al. Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement [published online September 12, 2017]. Catheter Cardiovasc Interv. doi:10.1002/ccd.27312.
84.
GregorySHZollerJKShahanavazSChilsonKLRidleyCH. Anesthetic considerations for transcatheter pulmonary valve replacement [published online June 3, 2017]. J Cardiothorac Vasc Anesth. doi:10.1053/j.jvca.2017.06.002.
85.
BauerUMMHelmPCDillerGPet al. Are adults with congenital heart disease informed about their risk for infective endocarditis and treated in accordance to current guidelines?Int J Cardiol. 2017;245:105-108.
86.
LabombardaFHamiltonRShohoudiAet al. Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease. J Am Coll Cardiol. 2017;70:857-865.
87.
YangHKuijpersJMde GrootJRet al. Impact of atrial arrhythmias on outcome in adults with congenital heart disease. Int J Cardiol. 2017;248:152-154.
88.
AvilaPOliverJMGallegoPet al. Natural history and clinical predictors of atrial tachycardia in adults with congenital heart disease. Circ Arrhythm Electrophysiol. 2017;10:e005396.
89.
LundqvistCBPotparaTSMalmborgH. Supraventricular arrhythmias in patients with adult congenital heart disease. Arrhythm Electrophysiol Rev. 2017;6:42-49.
90.
McLeodCJ. Acute arrhythmias in adults with congenital heart disease. Heart. 2017;103:1380-1388.
91.
MooreBYuCKotchetkovaICordinaRCelermajerDS. Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease [published online December 5, 2017]. Int J Cardiol. doi:10.1016/j.ijcard.2017.11.117.
92.
PundiKNPundiKNJohnsonJNet al. Sudden cardiac death and late arrhythmias after the Fontan operation. Congenit Heart Dis. 2017;12:17-23.
93.
VehmeijerJTKoyakZBudtsWet al. Prevention of sudden cardiac death in adults with congenital heart disease: do the guidelines fall short?Circ Arrhythm Electrophysiol. 2017;10:e005093.
94.
CecchinFHalpernDG. Cardiac arrhythmias in adults with congenital heart disease: pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices. Card Electrophysiol Clin. 2017;9:319-328.
95.
GiambertiAPluchinottaFRChessaMet al. Surgery for supraventricular tachycardia and congenital heart defects: long-term efficacy of the combined approach in adult patients. Europace. 2017;19:1542-1548.
96.
van WijkSWHvan der SteltFTer HeideHet al. Sudden death due to coronary artery lesions long-term after the arterial switch operation: a systematic review. Can J Cardiol. 2017;33:1180-1187.
97.
GiannakoulasGNtiloudiD. Acquired cardiovascular disease in adult patients with congenital heart disease [published online September 4, 2017]. Heart. doi:10.1136/heartjnl-2017-311997.
98.
BokmaJPZegstrooIKuijpersJMet al. Factors associated with coronary artery disease and stroke in adults with congenital heart disease [published online August 28, 2017]. Heart. doi:10.1136/heartjnl-2017-311620.
99.
KarangelisDMazineANarsupalliSMendisSVeldtmanGNikolaidisN. Morbidity after cardiac surgery in patients with adult congenital heart disease in comparison with acquired disease [published online June 28, 2017]. Heart Lung Circ. doi:10.1016/j.hlc.2017.05.133.
100.
NasrVGFaraoniDValenteAMDiNardoJA. Outcomes and costs of cardiac surgery in adults with congenital heart disease. Pediatr Cardiol. 2017;38:1359-1364.
